Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Houslay

Showing results (101-110 of 273) with videos related to

Pageof 28
Sort By:
Molecular Pharmacology|October 20, 2001
Phorbol 12-myristate 13-acetate triggers the protein kinase A-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving extracellular signal regulated kinase (ERK)G Baillie, S J MacKenzie, M D Houslay
The Biochemical Journal|April 15, 1996
Streptozotocin-induced diabetes elicits the phosphorylation of hepatocyte Gi2 alpha at the protein kinase C site but not at the protein kinase A-controlled siteN J Morris, M Bushfield, M D Houslay
The Biochemical Journal|September 15, 1989
Subcellular localization and hormone sensitivity of adipocyte cyclic AMP phosphodiesteraseN G Anderson, E Kilgour, M D Houslay
Biochimica Et Biophysica Acta|May 12, 1987
Quinidine and melittin both decrease the fluidity of liver plasma membranes and both inhibit hormone-stimulated adenylate cyclase activityL Needham, N J Dodd, M D Houslay
The Biochemical Journal|August 15, 1984
Islet-activating protein blocks glucagon desensitization in intact hepatocytesC M Heyworth, E Hanski, M D Houslay
The Journal of Endocrinology|July 1, 1989
Metformin treatment of lean and obese Zucker rats modulates the ability of glucagon and insulin to regulate hepatocyte adenylate cyclase activityD J Gawler, A Wilson, M D Houslay
Cellular Signalling|November 26, 1999
Genomic organisation of the human cyclic AMP-specific phosphodiesterase PDE4C gene and its chromosomal localisation to 19p13.1, between RAB3A and JUNDM Sullivan, A S Olsen, M D Houslay
The Biochemical Journal|June 15, 1993
Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipramY Shakur, J G Pryde, M D Houslay
FEBS Letters|April 5, 1983
Guanine nucleotides can activate the insulin-stimulated phosphodiesterase in liver plasma membranesC M Heyworth, S Rawal, M D Houslay
Biochemical Pharmacology|December 1, 1987
Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissueB Price, N J Pyne, M D Houslay
Pageof 28

Showing results (101-110 of 273) with videos related to

Sort By:
Pageof 28
Molecular Pharmacology|October 20, 2001
Phorbol 12-myristate 13-acetate triggers the protein kinase A-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving extracellular signal regulated kinase (ERK)G Baillie, S J MacKenzie, M D Houslay
The Biochemical Journal|April 15, 1996
Streptozotocin-induced diabetes elicits the phosphorylation of hepatocyte Gi2 alpha at the protein kinase C site but not at the protein kinase A-controlled siteN J Morris, M Bushfield, M D Houslay
The Biochemical Journal|September 15, 1989
Subcellular localization and hormone sensitivity of adipocyte cyclic AMP phosphodiesteraseN G Anderson, E Kilgour, M D Houslay
Biochimica Et Biophysica Acta|May 12, 1987
Quinidine and melittin both decrease the fluidity of liver plasma membranes and both inhibit hormone-stimulated adenylate cyclase activityL Needham, N J Dodd, M D Houslay
The Biochemical Journal|August 15, 1984
Islet-activating protein blocks glucagon desensitization in intact hepatocytesC M Heyworth, E Hanski, M D Houslay
The Journal of Endocrinology|July 1, 1989
Metformin treatment of lean and obese Zucker rats modulates the ability of glucagon and insulin to regulate hepatocyte adenylate cyclase activityD J Gawler, A Wilson, M D Houslay
Cellular Signalling|November 26, 1999
Genomic organisation of the human cyclic AMP-specific phosphodiesterase PDE4C gene and its chromosomal localisation to 19p13.1, between RAB3A and JUNDM Sullivan, A S Olsen, M D Houslay
The Biochemical Journal|June 15, 1993
Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipramY Shakur, J G Pryde, M D Houslay
FEBS Letters|April 5, 1983
Guanine nucleotides can activate the insulin-stimulated phosphodiesterase in liver plasma membranesC M Heyworth, S Rawal, M D Houslay
Biochemical Pharmacology|December 1, 1987
Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissueB Price, N J Pyne, M D Houslay
Pageof 28